Simvastatin 20 mg
Sponsors
University of Oxford, Organon and Co, Charite University, Berlin, Germany, Abbott, Judit Pich
Conditions
Arthritis, RheumatoidCirrhoses, LiverCoronary DiseaseDiabetes Mellitus, Type 2DyslipidemiaHypercholesterolemiaKidney Disease, ChronicMajor Depressive Disorder
Phase 2
Phase 3
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
CompletedNCT00423488
Start: 2005-07-12End: 2007-02-16Updated: 2022-02-09
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
CompletedNCT01674712
Start: 2012-06-30End: 2013-10-31Updated: 2014-12-11
Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
CompletedNCT03435744
Start: 2019-01-01End: 2021-06-30Updated: 2021-08-26
Phase 4
Study of Heart and Renal Protection
CompletedNCT00125593
Start: 2003-06-30End: 2010-08-31Updated: 2012-02-01
Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients
NCT00842920
Start: 2008-12-31End: 2021-02-28Target: 520Updated: 2020-01-27
NIRS to Diagnose SAMS
NCT03653663
Start: 2018-01-01End: 2020-07-30Target: 40Updated: 2020-02-13
Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis
CompletedNCT04177173
Start: 2017-09-01End: 2018-12-14Updated: 2019-11-26